/
Login
Total Market Cap
780.8B
P/E (Weighted)Price to Earnings ratio.
21.48
Medyan: 18.61
P/B (Weighted)Price to Book ratio.
2.05
Medyan: 0.87
P/E (Arithmetic)Simple average P/E.
21.98
Avg Lothien ScoreFinancial health score (0-100).
47
Avg DamodaranDamodaran scoring model.
29
Avg PotentialExpected upside potential %.
+15.0%
Avg Dalio ScoreDalio debt cycle score.
54
Distributions
Lothien Distribution
Damodaran Distribution
Upside Potential
Stocks in Sector
| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NTGAZ
|
11.32 | 7.8B | 5.97 | 1.28 | 2.61 | 24.8% | 39.7% | 79 | 47 | 24.79 | +89.2% | 96 | 0.09 |
|
ARASE
|
120.00 | 30.0B | 11.12 | 1.34 | 3.40 | 27.9% | 39.1% | 69 | 36 | 174.29 | +32.6% | 80 | 0.13 |
|
CATES
|
69.05 | 11.4B | 7.64 | 0.86 | 3.78 | -2.6% | 41.8% | 68 | 27 | 123.80 | +54.7% | 81 | 0.01 |
|
AYDEM
|
25.96 | 18.3B | — | 0.45 | 4.89 | 2.0% | 23.2% | 65 | 52 | 63.16 | +98.9% | 49 | 0.57 |
|
GWIND
|
21.98 | 11.9B | 14.18 | 0.76 | 6.12 | 3.3% | 33.7% | 62 | 34 | 31.82 | +30.9% | 73 | 0.21 |
|
AKFYE
|
22.64 | 26.8B | 17.97 | 0.43 | 12.28 | 1.1% | 28.5% | 58 | 32 | 36.64 | +36.5% | 50 | 0.21 |
|
CANTE
|
1.34 | 13.4B | — | 0.43 | 11.54 | -1.6% | 40.9% | 54 | 31 | 2.53 | +50.0% | 73 | 0.02 |
|
ENJSA
|
114.50 | 135.2B | 17.77 | 1.34 | 4.57 | 12.8% | 30.3% | 54 | 40 | 119.82 | +3.1% | 49 | 0.89 |
|
AHGAZ
|
38.84 | 98.6B | 26.32 | 1.80 | 6.16 | 18.5% | 36.8% | 53 | 44 | 43.69 | +9.0% | 72 | 0.15 |
|
ESEN
|
3.31 | 6.0B | — | 0.50 | 21.89 | 0.5% | 23.6% | 53 | 31 | 5.43 | +32.6% | 23 | 0.67 |
|
ZOREN
|
2.30 | 11.5B | — | 0.19 | 8.85 | -0.1% | 13.9% | 52 | 36 | 4.61 | +51.3% | 28 | 0.96 |
|
ODAS
|
7.28 | 10.2B | 39.67 | 0.65 | 2.24 | -2.2% | 40.9% | 51 | 22 | 14.05 | +59.5% | 69 | 0.11 |
|
NATEN
|
4.97 | 4.1B | — | 0.53 | 23.52 | -2.7% | 20.6% | 50 | 29 | 7.90 | +30.2% | 18 | 1.05 |
|
CONSE
|
2.24 | 1.7B | 23.66 | 0.80 | 7.32 | -0.4% | 10.3% | 49 | 36 | 2.53 | +7.6% | 35 | 3.14 |
|
PRKME
|
18.21 | 2.7B | — | 0.53 | 7.92 | 0.0% | 44.0% | 49 | 23 | 25.96 | +27.2% | 64 | 0.00 |
|
ZEDUR
|
7.45 | 1.3B | 16.86 | 0.74 | 7.90 | -0.3% | 39.3% | 49 | 31 | 8.90 | +11.5% | 48 | 0.18 |
|
AYEN
|
30.26 | 8.4B | 34.08 | 0.45 | 6.32 | 3.4% | 24.9% | 48 | 40 | 44.00 | +30.4% | 53 | 0.38 |
|
AKENR
|
10.08 | 7.3B | — | 0.51 | 23.73 | -1.4% | 14.1% | 46 | 32 | 15.62 | +28.1% | 15 | 1.64 |
|
ENERY
|
10.50 | 94.5B | 18.61 | 1.60 | 10.24 | 6.4% | 38.3% | 44 | 22 | 8.12 | -17.0% | 76 | 0.06 |
|
IZENR
|
6.47 | 15.8B | 32.12 | 0.87 | 7.84 | 3.8% | 40.2% | 44 | 24 | 5.79 | -7.6% | 78 | 0.06 |
|
HUNER
|
3.88 | 3.9B | — | 0.79 | 9.01 | 2.8% | 29.6% | 43 | 25 | 4.18 | +4.6% | 42 | 0.40 |
|
MOGAN
|
13.96 | 34.1B | — | 1.43 | 13.01 | 6.2% | 36.3% | 43 | 44 | 14.58 | +2.6% | 34 | 0.99 |
|
YAYLA
|
20.50 | 1.0B | — | 1.24 | 90.16 | -2.3% | 44.0% | 37 | 17 | 14.54 | -16.3% | 76 | 0.00 |
|
TATEN
|
7.59 | 8.5B | 37.63 | 1.49 | 10.09 | 5.9% | 24.6% | 36 | 23 | 6.40 | -10.5% | 43 | 1.27 |
|
AKSEN
|
79.35 | 97.3B | 26.35 | 1.52 | 11.86 | 4.6% | 25.5% | 35 | 24 | 52.37 | -24.5% | 54 | 0.89 |
|
AKSUE
|
28.82 | 1.9B | — | 2.50 | 66.87 | -0.9% | 43.8% | 30 | 16 | 11.79 | -33.1% | 73 | 0.02 |
|
PAMEL
|
73.35 | 2.3B | — | 3.42 | — | -0.1% | 44.0% | 25 | 14 | 26.30 | -30.8% | 72 | 0.00 |
|
BIOEN
|
18.61 | 9.3B | — | 2.84 | 14.88 | -4.3% | 27.7% | 24 | 25 | 10.20 | -23.1% | 26 | 1.78 |
|
MAGEN
|
33.90 | 100.0B | — | 6.57 | 145.36 | 0.6% | 37.3% | 24 | 10 | 8.47 | -38.3% | 38 | 0.53 |
|
MANAS
|
35.58 | 5.5B | — | 9.19 | 98.39 | 3.2% | 40.2% | 19 | 13 | 8.89 | -38.2% | 45 | 0.73 |